Hearing on Exploring the Effects of Consolidation and Anticompetitive Conduct in Health Care Markets

Video here. 

The Opportunity Costs of Socialism

US Council of Economic Advisers, here.
Don't ask.

Santé: ouverture d’une consultation publique

Autorité de la concurrence, ici. 

The First Wealth is Health: Protecting Competition in Healthcare Markets

M. Ohlhausen, here. 

Judge, Citing Harm to Customers, Blocks $48 Billion Anthem-Cigna Merger

NYTimes, here. 

How Much of Health Care Antitrust is Really Antitrust?

S. Weber Waller, here. 

The Teladoc Case: Antitrust and Telemedicine as "Disruptive Innovation"

Lexology, here.

Competition problems provisionally found in private healthcare

CMA, Report here. Notice of possible remedies here. 

Takeaways From the FTC/DOJ Workshop on Health Care Competition

Foley & Lardner, here.

The Meaning of ‘Relevant Customer Benefits’ in the Context of Health Care: Monitor’s Advice and the Competition Commission’s Response

M. Guy, here. 

OFT refers private healthcare market to Competition Commission

Here.

Assicurazioni: multe per oltre 13 milioni a tre imprese e a un’agenzia plurimandataria per intesa restrittiva della concorrenza

I731, qui.

FTC Staff Says Proposed New York Legislation Would Reduce Competition and Likely Lead to Higher Prescription Drug Costs

Here.